Miriam J. Warnier
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol.
Journal: Pharmacoepidemiology and drug safety
Published: September 20, 2014
Quality of drug label information on QT interval prolongation.
Journal: The International journal of risk & safety in medicine
Published: June 07, 2014
Safety information on QT-interval prolongation: comparison of European Union and United States drug labeling.
Journal: Drug discovery today
Published: December 16, 2013
Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia.
Journal: PloS one
Published: November 12, 2013
Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease.
Journal: COPD
Published: February 19, 2013
QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.
Journal: The Journal of clinical psychiatry
Published: January 31, 2013
Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control study.
Journal: PloS one
Published: October 22, 2012
Cardiac arrhythmias in adult patients with asthma.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: September 28, 2012
Smoking cessation strategies in patients with COPD.
Journal: The European respiratory journal
Published: September 01, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026